Concentrix Corp — Director's Dealing 2023

Sep 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2023-09-25

Reporting Person: Duha Olivier (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-25	Common Stock	A	1177480	—	Acquired	1177480	Direct
2023-09-25	Common Stock	A	1173	—	Acquired	1178653	Direct
2023-09-25	Common Stock	A	322066	—	Acquired	322066	Indirect
2023-09-25	Common Stock	A	36041	—	Acquired	36041	Indirect

Footnotes

F1: On September 25, 2023, the Issuer completed its acquisition of the issued and outstanding capital stock of Marnix Lux SA, a public limited company (societe anonyme) organized under the Laws of the Grand Duchy of Luxembourg ("Marnix Lux"), the parent company of Webhelp, pursuant to the Share Purchase and Contribution Agreement dated June 12, 2023, as amended by the First Amendment to the Share Purchase and Contribution Agreement, dated July 14, 2023 by and among the Issuer, OSYRIS S.a.r.l., Marnix Lux and the holders of Marnix Lux (the "Transaction", and such agreement, as amended, the "Agreement").

F2: In connection with the Transaction, the Reporting Person received 1,177,480 shares of the Issuer as well as cash, a portion of the Sellers' Note (as defined in the Agreement) and a contractual right to receive up to an additional 59,421 shares of the Issuer subject to certain conditions set forth in the Agreement (which right became fixed and irrevocable on the effective date of the Transaction) in exchange for (i) certain shares of Marnix Lux and (ii) the contribution of a Vendor Loan (as defined in the Agreement) received in connection with the acquisition by the Issuer of certain other shares of Marnix Lux, representing a total of 17,551,332 shares of Marnix Lux. On the effective date of the Transaction, the closing price of Concentrix' common stock was $73.92 per share.

F3: Represents restricted stock units under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the date of the Issuer's 2024 Annual Meeting of Stockholders.

F4: In connection with the Transaction, the Reporting Person received 322,066 shares of the Issuer as well as cash, a portion of the Sellers' Note and a contractual right to receive up to an additional 16,252 shares of the Issuer subject to certain conditions set forth in the Agreement (which right became fixed and irrevocable on the effective date of the Transaction) in exchange for (i) certain shares of Marnix Lux and (ii) the contribution of a Vendor Loan received in connection with the acquisition by the Issuer of certain other shares of Marnix Lux, representing a total of 4,839,231 shares of Marnix Lux. On the effective date of the Transaction, the closing price of Concentrix' common stock was $73.92 per share.

F5: In connection with the Transaction, the Reporting Person received 36,041 shares of the Issuer as well as cash, a portion of the Sellers' Note and a contractual right to receive up to an additional 1,818 shares of the Issuer subject to certain conditions set forth in the Agreement (which right became fixed and irrevocable on the effective date of the Transaction) in exchange for (i) certain shares of Marnix Lux and (ii) the contribution of a Vendor Loan received in connection with the acquisition by the Issuer of certain other shares of Marnix Lux, representing a total of 1,071,490 shares of Marnix Lux. On the effective date of the Transaction, the closing price of Concentrix' common stock was $73.92 per share.